Relationship of promising methods in the detection of anthracycline-induced cardiotoxicity in breast cancer patients

被引：0
作者：
Ben F. Bulten
Hein J. Verberne
Louise Bellersen
Wim J. G. Oyen
Aida Sabaté-Llobera
Annelies M. C. Mavinkurve-Groothuis
Livia Kapusta
Hanneke W. M. van Laarhoven
Lioe-Fee de Geus-Oei
机构：
[1] University of Twente,MIRA Institute for Biomedical Technology and Technical Medicine
[2] Radboudumc,Department of Radiology and Nuclear Medicine
[3] Academic Medical Center,Department of Nuclear Medicine
[4] Radboudumc,Department of Cardiology
[5] Hospital Universitari de Bellvitge,Department of Nuclear Medicine
[6] Princess Maxima Center for Pediatric Oncology,Department of Children’s Heart Center
[7] Radboudumc,Pediatric Cardiology Unit
[8] Tel Aviv Sourasky Medical Center,Department of Medical Oncology
[9] Academic Medical Center,Department of Medical Oncology
[10] Radboudumc,Section of Nuclear Medicine, Department of Radiology
[11] Leiden University Medical Center,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2015年 / 76卷
关键词：
Breast cancer; Anthracyclines; Cardiotoxicity; 2D strain imaging; I-; IBG scintigraphy; Biomarkers;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：957 / 967
页数：10
相关论文
共 50 条
[41]   Precision Treatment of Anthracycline-Induced Cardiotoxicity: An Updated Review [J].
Kuang, Ziyu ;
Ge, Yuansha ;
Cao, Luchang ;
Wang, Xinmiao ;
Liu, Kexin ;
Wang, Jiaxi ;
Zhu, Xiaojuan ;
Wu, Min ;
Li, Jie .
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2024, 25 (08) :1038-1054
[42]   Managing anthracycline-induced cardiotoxicity: beginning with the end in mind [J].
Salvatorelli, Emanuela ;
Menna, Pierantonio ;
Minotti, Giorgio .
FUTURE CARDIOLOGY, 2015, 11 (04) :363-366
[43]   Anthracycline-Induced Cardiotoxicity: Time to Focus on Cardioprotection Again [J].
Croft, A. J. ;
Ngo, D. T. M. ;
Sverdlov, A. L. .
HEART LUNG AND CIRCULATION, 2019, 28 (10) :1454-1456
[44]   Molecular mechanisms of anthracycline-induced cardiotoxicity and its prevention [J].
Andrieu-Abadie, N .
THERAPIE, 2004, 59 (01) :121-126
[45]   Molecular basis of anthracycline-induced cardiotoxicity and its prevention [J].
Horenstein, MS ;
Vander Heide, RS ;
L'Ecuyer, TJ .
MOLECULAR GENETICS AND METABOLISM, 2000, 71 (1-2) :436-444
[46]   Anthracycline-Induced Cardiotoxicity Remembering the Forgotten Ventricle COMMENT [J].
Liu, Jennifer E. .
JACC: CARDIOONCOLOGY, 2020, 2 (01) :23-25
[47]   Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management [J].
Barry, Elly ;
Alvarez, Jorge A. ;
Scully, Rebecca E. ;
Miller, Tracie L. ;
Lipshultz, Steven E. .
EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (08) :1039-1058
[48]   Pharmacogenomic study of anthracycline-induced cardiotoxicity in Mexican pediatric patients [J].
Vargas-Neri, Jessica L. ;
Carleton, Bruce ;
Ross, Colin J. ;
Medeiros, Mara ;
Castaneda-Hernandez, Gilberto ;
Clark, Patricia .
PHARMACOGENOMICS, 2022, 23 (04) :291-301
[49]   Protective Effects of ω-3 PUFA in Anthracycline-Induced Cardiotoxicity: A Critical Review [J].
Serini, Simona ;
Vasconcelos, Renata Ottes ;
Gomes, Renata Nascimento ;
Calviello, Gabriella .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (12)
[50]   Anthracycline-induced cardiotoxicity in patients with early-stage breast cancer: the Canadian Cancer Trials Group (CCTG) MA.21 experience [J].
Dent, S. F. ;
Botros, J. ;
Rushton, M. ;
Aseyev, O. ;
Levine, M. N. ;
Parulekar, W. R. ;
O'Brien, P. ;
Burnell, M. ;
Pritchard, K. I. ;
Chen, B. E. ;
Shepherd, L. E. .
BREAST CANCER RESEARCH AND TREATMENT, 2020, 184 (03) :733-741
12345